Bone Densitometry and Osteogenesis Imperfecta
Bone densitometry can be beneficial in diagnosing osteogenesis imperfecta (OI). One of the most consistent features of the skeletal defect in osteogenesis imperfecta is low bone density. Bone densitometry can be helpful in assessing skeletal development in children with OI and determining the likelihood of fractures. Bone densitometry also allows physicians to assess the possible effects of injuries, illness, and/or medications in patients with OI. Contact your doctor for more information on bone densitometry and osteogenesis imperfecta.
One of the most consistent features of the skeletal defect in osteogenesis imperfecta (OI) is low bone density, a major reason for excess skeletal fragility and fractures in this disorder. Bone densitometry (also known as a bone density test or bone density scan) can be helpful in assessing skeletal development in children with osteogenesis imperfecta and determining the likelihood of fractures. It can also be useful to assess the possible effects of injuries, illness and/or medications in patients with OI. Bone densitometry allows physicians to assess the effects of treatments designed to build up bone mass or prevent bone loss.
While bone densitometry measurements may be useful in the management of anyone with OI, individuals with Type I osteogenesis imperfecta usually benefit most. They have the longest life span among people with OI and will be faced with the bone loss associated with menopause, immobilization, medications (such as cortisone-like drugs), etc. Thus, bone density measurements may be most useful in managing these problems, particularly menopause.
With other types of osteogenesis imperfecta, the skeletal defects tend to be worse, the bone density is extremely low, and osteogenesis imperfecta treatment is difficult regardless of bone density. However, bone density measurements may be useful in monitoring the skeletal condition of these patients.